课题基金 / 基金详情

Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK.

Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK.
异氟醚通过抑制蛋白激酶、JNK 和 ERK 来保护肾功能免受缺血和再灌注的影响。
批准号:
15591639
负责人:
MOROOKA Hiroaki
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

MOROOKA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
缺血再灌注损伤(Ischemia/reperfusion injury, IRI)是外科手术中的一个主要问题。异氟醚在心脏和大脑中具有抗IR的药理预处理作用,但这种作用是否也发生在肾脏中尚不清楚。在本研究中,我们验证了异氟醚对大鼠肾脏IRI具有保护作用的假设,并进一步证明了JNK抑制有助于这种保护作用。动物被随机分为四组。F组仅行假手术。G组假手术前使用1.5%异氟醚。H组和I组左肾缺血40 min,夹持肾蒂。组1在肾缺血前给予1.5%异氟醚治疗20 min。在开始再灌注后0、5、40和90分钟收获缺血肾,在假手术后40分钟收获假肾,测量JNK活性。H组(仅缺血)JNK早在再灌注开始后5分钟就明显激活,在40分钟达到峰值,并在再灌注开始后90分钟保持较高水平。再灌注后40 ~ 90 min,异氟醚组JNK活性明显低于H组。我们得出结论,异氟醚在缺血前给药对肾脏IRI具有保护作用,并且这种作用可能涉及抑制JNK。
英文摘要
Ischemia/reperfusion injury (IRI) is a major problem in the surgery. Isoflurane has a pharmacological preconditioning effect against IR in the heart and brain, but whether this also occurs in the kidney is still unclear. In this study, we tested the hypothesis that isoflurane had a protective effect against IRI in the rat kidney, and further that JNK inhibition contributed this protective effect.Animals were randomly divided into four groups. Group F underwent sham surgery only. Group G received 1.5% isoflurane before sham surgery. Groups H and I were subjected to 40-min left renal ischemia by clamping the renal pedicles. Group I received 1.5% isoflurane for 20 min before renal ischemia. Ischemic kidneys were harvested at 0, 5, 40 and 90 min after starting reperfusion, and sham kidneys were harvested at 40 min after sham surgery, for measurement of JNK activities.JNK was markedly activated as early as 5 min after starting reperfusion, with a peak at 40 min, and remained at a relatively high level until 90 min after starting reperfusion in group H (ischemia only). The activity of JNK in group I (with isoflurane) was significantly lower than in group H from 40 to 90 min after starting reperfusion. We conclude that isoflurane has a protective effect against renal IRI when administered before ischemia and that the effect would involve the inhibition of JNK.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1213/01.ane.0000184044.51749.b8
发表时间: 2005-12-01
期刊: ANESTHESIA AND ANALGESIA
影响因子: 5.7
作者: [Hashiguchi, H, Morooka, H, Sumikawa, K]
通讯作者: Sumikawa, K
DOI: 10.1007/s00540-005-0322-4
发表时间: 2005-08
期刊: Journal of Anesthesia
影响因子: 2.8
作者: [Y. Terao;Toshiaki Nakamura;H. Morooka;K. Sumikawa]
通讯作者: Y. Terao;Toshiaki Nakamura;H. Morooka;K. Sumikawa
Masanori Matsumoto, et al.: "Isoflurane inhibits NFkB activation in response to simulated ischemia in renal tubular cell line"Anesthesiology. 99. A1545 (2003)
Masanori Matsumoto 等人:“异氟醚抑制肾小管细胞系中模拟缺血反应中的 NFkB 激活”麻醉学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Effect of Cyclooxygenase-2 inhibitor pretreatment on gas exchange after hydrochloric acid asniration in rats.
环氧合酶 2 抑制剂预处理对大鼠盐酸吸入后气体交换的影响。
DOI: --
发表时间: 2005
期刊: Journal of Anesthesia 19
影响因子: --
作者: [Yoshiaki Terao, Hiroaki Morooka, et al.]
通讯作者: et al.
7
    Pharmacological preconditioning effect of isoflurane against renal ischemia/reperfusion injury in rats.
    • 批准号:
      14571448
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2002
    • 负责人:
      MOROOKA Hiroaki
    • 依托单位:
    N-acetyl-L-cysteine inhibits activitation of p38 MAP kinase in heat stressed heart
    • 批准号:
      11671507
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      1999
    • 负责人:
      MOROOKA Hiroaki
    • 依托单位:
    国内基金
    海外基金
    丁酸通过抑制p38/ERK/JNK信号通路重建Treg/Th17平衡缓解艰难梭菌结肠炎的机制研究
    circFOXM1通过CTCF/TP53轴调控糖酵解与JNK通路诱导胶质瘤替莫唑胺耐药的机制与转化研究
    • 批准号:
      2026JJ82323
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚勇
    • 依托单位:
    DUSP10通过抑制JNK/P38延缓肾脏缺血再灌注纤维化的关键机制研究
    • 批准号:
      2026JJ50647
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      郭勇
    • 依托单位:
    CDH5介导p38/JNK通路调控糖尿病视网膜病变的分子机制及干预探索
    • 批准号:
      2026JJ80392
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王桂芳
    • 依托单位: